(Q41135739)
Statements
1 reference
Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies (English)
1 reference
Raymond L Erikson
Toshiyuki Sakai
Jong-Seog Ahn
6 September 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference